All In Biotech

Drug Trial Radar · NCT07159841

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension

Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 153 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

153

Planned (sponsor's estimate)

Start

Jan 22, 2026

Primary completion

Mar 2030

Study completion Mar 2030

Sponsor

Lead sponsor
Crinetics Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Sep 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).

Conditions

  • Congenital Adrenal Hyperplasia
  • Classic Congenital Adrenal Hyperplasia

Interventions

  • AtumelnantDrug

    Atumelnant, tablets, once daily by mouth, weight-based dosing

  • PlaceboDrug

    Placebo, tablets, once daily by mouth, weight-based dosing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in morning serum androstenedione (A4) (Part A)Time frame: Week 8
  2. Percent change from baseline in glucocorticoid (GC) daily dose while serum early morning A4 ≤Upper Limit of Normal (ULN) (Part B)Time frame: Week 28
  3. Change from baseline in serum early morning A4 over time (Part C)Time frame: Up to Week 260

Locations

53 sites in 13 countries. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • UCSF Ron Conway Gateway Medical Building

    San Francisco, California · Recruiting

  • Ann and Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • Boston's Children's Hospital

    Boston, Massachusetts · Recruiting

  • University of Michigan

    Ann Arbor, Michigan · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • Rutgers Robert Wood Johnson Medical School

    New Brunswick, New Jersey · Recruiting

  • Icahn School of Medicine at Mount Sinai-Mount Sinai Hospital

    New York, New York · Recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • Cook Children's Health Care System

    Fort Worth, Texas · Recruiting

  • University of Virginia Health System

    Charlottesville, Virginia · Recruiting

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina · Recruiting

  • Instituto Médico Especializado (IME)

    Buenos Aires, Argentina · Recruiting

  • CEDIE "Centro de Investigaciones Endocrinológicas", CONICET-FEI División de Endocrinología, Hosp de Niños Ricardo Gutiérrez

    Buenos Aires, Argentina · Recruiting

  • Instituto de Investigaciones Metabólicas

    Buenos Aires, Buenos Aires, Argentina · Recruiting

  • Hospital de Niños de la Santísima Trinidad

    Córdoba, Córdoba Province, Argentina · Recruiting

  • Institute of Endocrinology of Diabetes, The Children's Hospital at Westmead

    Westmead, New South Wales, Australia · Withdrawn

  • Queensland Children's Hospital

    South Brisbane, Queensland, Australia · Not yet recruiting

  • Monash Children's Hospital, Monash Health

    Clayton, Victoria, Australia · Recruiting

  • Perth Children's Hospital

    Nedlands, Western Australia, Australia · Not yet recruiting

  • UZA (Antwerp University Hospital)

    Edegem, Antwerp, Belgium · Recruiting

  • Cliniques Universitaires Saint-Luc

    Brussels, Brussels Capital, Belgium · Recruiting

  • UZ Gent (University Hospital Ghent)

    Ghent, East Flanders, Belgium · Recruiting

  • UZ Leuven (Universitair Ziekenhuis Leuven)

    Leuven, Flemish Brabant, Belgium · Recruiting

  • Nucleo de Pesquisa Clinica do Rio Grande do Sul

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

    Ribeirão Preto, São Paulo, Brazil · Recruiting

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP)

    São Paulo, São Paulo, Brazil · Recruiting

  • Hospital las Hilgueras de Talcahuano

    Talcahuano, Chile · Recruiting

  • Instituto de Investigaciones Materno Infantil IDIMI, Facultad de Medicina de la Universidad de Chile

    Santiago, Santiago Metropolitan, Chile · Recruiting

  • Centre Hospitalier Universitaire (CHU) d'Angers

    Angers, France · Recruiting

  • Hopital Kremlin-Bicétre - APHP Paris Saclay

    Le Kremlin-Bicêtre, France · Recruiting

  • Hopital Jeanne de Flandre - CHU de Lille

    Lille, France · Recruiting

  • APHM -Hopital La Timone Enfants

    Marseille, France · Recruiting

  • Hopital Necker - Enfants Malades

    Paris, France · Recruiting

  • Hopital Robert Debre

    Paris, France · Recruiting

  • Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum Klinik für pädiatrische Endokrinologie und Diabetologie

    Berlin, Germany · Recruiting

  • Universitätsklinikum Tübingen Klinik fur Kinder und Jugendmedizin

    Tübingen, Baden, Germany · Recruiting

  • Universitatsklinikum Koln Klinik und Poliklinik fur Kinder- und Jugendmedizin

    Cologne, North Rhine-Westphalia, Germany · Recruiting

  • AOU Federico II

    Naples, Campania, Italy · Recruiting

  • IRCCS Istituto Giannina Gaslini

    Genoa, Liguria, Italy · Recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.